Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: UMLS:C0432222 (SEM)
 47,337 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

This study was conducted to determine whether intrauterine infusion of recombinant bovine interferon-alpha I1 (rboIFN-alpha I1), which has 70% sequence identity to bovine trophoblast protein-1, will prevent regression of corpora lutea anticipated to have a short lifespan. Twenty-six beef cows in good body condition were allotted to four treatment groups at parturition in a 2 x 2 factorial design. Treatments were: group 1, saline; group 2, rboIFN-alpha I1; group 3, norgestomet-saline; and group 4, norgestomet-rboIFN-alpha I1. Norgestomet implants were inserted on days 21-24 postpartum and removed 9 days later (before injection of human chorionic gonadotrophin (hCG)). Ovulation was induced 30 to 33 days postpartum with 5000 or 10,000 iu hCG. Groups 1 (n = 7) and 3 (n = 5) were given intrauterine infusions (rectocervical approach) twice daily with saline on days 1-12 or 13-24 after hCG injection, respectively. Cows allotted to groups 2 (n = 8) and 4 (n = 6) were given intrauterine infusions (rectocervical approach) of 2 mg rboIFN-alpha I1 twice daily on days 1-12 or 13-24 after hCG injection, respectively. Treatment with both norgestomet and rboIFN-alpha I1 delayed (P less than 0.01) luteolysis. Lengths of luteal phases (days; mean +/- SEM) were 8.4 +/- 0.7 (group 1, saline), 14.1 +/- 1.0 (group 2, rboIFN-alpha I1), 18.6 +/- 1.3 (group 3, norgestomet-saline) and 20.8 +/- 1.2 (group 4, norgestomet-rboIFN-alpha I1). Concentration of progesterone in serum was similar among all groups the first 6 days following hCG-induced ovulation, but differed (P less than 0.01) thereafter.(ABSTRACT TRUNCATED AT 250 WORDS)
 ...
PMID:Luteal function after intrauterine infusion of recombinant bovine interferon-alpha I1 into postpartum beef cows expected to have short or normal luteal phases. 159 34

To study sexual behavior and pregnancy rate of Zebu bulls, 9 Brahman and 6 Nelore bulls were first examined for libido and serving capacity, semen characteristics and scrotal circumference, a week before being placed, individually, into a group of 16 estrus-syncronized heifers to observe mating activity. Scores for libido (0 to 10) and for serving capacity (based on the number of services per period) were assigned for each bull over a 15-min period. Estrus was synchronized with Norgestomet (3 mg, s.c. implant and 3 mg, i.m.) and estradiol valerate (5 mg, i.m.). The implants remained in place for 10 d, then 40 h after their removal a bull was placed with the heifers. Four Brahman and 6 Nelore bulls were monitored for 2 h while the remaining 5 Brahman bulls were observed for 30 h. Number of services and mounts per bull, the hour at which each event took place, and the identification of the heifers serviced were recorded. Pregnancy was diagnosed by transrectal palpation 50 to 60 d after mating. Mean libido score (+/- SEM) of the 15 bulls was 6.4 +/- 0.5, and mean serving capacity was 0.53 +/- 0.19; both of these measures were correlated with age (r = 0.78, P < 0.01, and r = 0.56, P < 0.05, respectively). In the 2-h trials, the number of mounts was correlated with the libido score (r = 0.73, P < 0.05), and the number of services was correlated with age (r = 0.76, P < 0.05) and with libido and serving capacity score (r = 0.91 and 0.92, P < 0.01). In the 30-h trials, the mean (+/- SEM) number of mounts and of services per bull was 74.4 +/- 21.1 and 14.6 +/- 0.5, respectively. The mount-to-service ratio and percentage of serving efficiency were 5.1 +/- 1.4, and 19.8 +/- 4%, respectively. Libido score was correlated with the mount-to-service ratio (r = -0.86, P < 0.10) and with serving efficiency (r = 0.84, P < 0.10). The percentage of heifers serviced, of those serviced 2 or more times and of those pregnant was 55 +/- 5.3; 47.1 +/- 6.4, and 59.2 +/- 5.8, respectively. Pregnancy rate was not correlated with any trait (P > 0.10). It was concluded that libido and the serving capacity test seem to indicate the mating potential of Zebu bulls over a relatively short period of time (e.g. 30 hours), in which resultant pregnancy rates are comparable to those of European bulls.
 ...
PMID:Sexual behavior and pregnancy rate of Bos indicus bulls. 1073 Sep 85

In bovine in vitro embryo production, the IVM step is rather successful with 80% of the oocytes reaching the MII stage. However, the extent to which the process limits the yield of viable embryos is still largely unknown. Therefore, we compared embryonic developmental capacity during IVC of IVF oocytes which had been matured in vitro with those matured in vivo. In vitro maturation was carried out for 22 h using oocytes (n = 417) obtained from 2- to 8-mm follicles of ovaries collected from a slaughterhouse in M199 with 10% fetal calf serum (FCS), 0.01 IU/mL LH, and 0.01 IU/mL FSH. In vivo matured oocytes (n = 219) were aspirated from preovulatory follicles in eCG/PG/anti-eCG-superovulated heifers 22 h after a fixed time GnRH-induced LH surge; endogenous release of the LH surge was suppressed by a Norgestomet ear implant. This system allowed for the synchronization of the in vitro and in vivo maturation processes and thus for simultaneous IVF of both groups of oocytes. The in vitro developmental potential of in vivo matured oocytes was twice as high (P < 0.01) as that of in vitro matured oocytes, with blastocyst formation and hatching rates 11 d after IVC of 49.3 +/- 6.1 (SEM; n = 10 heifers) vs 26.4 +/- 1.0% (n = 2 replicates), and 39.1 +/- 5.1% vs 20.6 +/- 1.4%, respectively. It is concluded that IVM is a major factor limiting in the in vitro production of viable embryos, although factors such as the lack of normal preovulatory development of IVM oocytes contributed to the observed differences.
 ...
PMID:Improved in vitro embryo development using in vivo matured oocytes from heifers superovulated with a controlled preovulatory LH surge. 1073 99

Forty-five nonpregnant, nonlactating, Angus and Brangus cows were utilized to determine how long a Norgestomet ear implant would inhibit estrus when administered at various stages of an estrous cycle. All cows completed a nontreated estrous cycle to ensure normal cyclicity. At the second observed estrus (estrus = Day 1), cows were randomly allotted to be treated at metestrus (Day 3 or Day 4, n = 15); at diestrus (Day 9 or Day 10, n = 14); or at proestrus (Day 15 or Day 16, n = 16). All cows received a 2-ml intramuscular injection of 3 mg of Norgestomet accompanied by a 6-mg Norgestomet ear implant, which remained in situ for 21 days, or until individual cows were observed in estrus. Estrus was inhibited for a mean (+/- SEM) of 18.7 +/- 0.7, 19.9 +/- 0.8, and 17.0 +/- 0.8 days, respectively, when cows were treated at metestrus, diestrus, and proestrus (metestrus and diestrus vs proestrus; P < 0.05). Estrus was inhibited for an entire 21-day implantation period in 27, 50, and 38% of cows treated at metestrus, diestrus, and proestrus, respectively (P > 0.10). Norgestomet inhibited estrus in all cows for 11, 17, and 11 days after implantation when treatment was initiated at metestrus, diestrus, and proestrus, respectively (P > 0.10). These data indicate that a 6-mg Norgestomet ear implant effectively inhibits estrus in all cows for a maximum of 11 days, with some cows exhibiting estrus by Day 12 with the Norgestomet implant in situ.
 ...
PMID:Inhibition of estrus and corpora lutea function with Norgestomet. 1672 59